Literature DB >> 34405873

Prevalence and predictors of long-acting reversible contraceptive use among sexually active women in 26 sub-Saharan African countries.

Obasanjo Afolabi Bolarinwa1, Ugochinyere Ijeoma Nwagbara1, Joshua Okyere2, Bright Opoku Ahinkorah3, Abdul-Aziz Seidu2,4,5, Edward Kwabena Ameyaw3, Victor Igharo6.   

Abstract

BACKGROUND: Long-acting reversible contraceptives (LARCs) are associated with high efficacy rates and continuity of use. Based on the foregoing, we sought to examine the prevalence and factors associated with LARC use among sexually active women in 26 countries in sub-Saharan Africa(SSA).
METHODS: Secondary data from Demographic and Health Surveys conducted in 26 countries in SSA between January 2010 and December 2019 were pooled and analysed. A total of 56 067 sexually active women 15-49 y of age met the inclusion criteria. Bivariate and multivariate regression analyses were performed to examine the association between selected factors and the use of LARCs in SSA. Results were presented as crude odds ratios and adjusted odds ratios (aORs) with statistical precision at <0.05.
RESULTS: The prevalence of LARC use was 21.73%, ranging from 1.94% in Namibia to 54.96% in Benin. Sexually active women with secondary or higher education (aOR 1.19 [95% confidence interval {CI} 1.08 to 1.32]), those cohabiting (aOR 1.25 [95% CI 1.06 to 1.47]) and those with four or more children (aOR 2.22 [95% CI 1.78 to 2.78]) were more likely to use LARCs compared with those without education, never married and with no biological child.
CONCLUSIONS: The use of LARCs in the 26 countries in SSA was relatively low. Hence, the identified contributory factors of LARC use should be tackled with appropriate interventions. These include continuous campaigns on the efficacy of LARCs in reducing unintended pregnancy, maternal mortality and morbidity.
© The Author(s) 2021. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Entities:  

Keywords:  contraceptive; long-acting reversible; predictors; public health; sexually active women; sub-Saharan African

Mesh:

Substances:

Year:  2022        PMID: 34405873      PMCID: PMC9450634          DOI: 10.1093/inthealth/ihab053

Source DB:  PubMed          Journal:  Int Health        ISSN: 1876-3405            Impact factor:   3.131


Introduction

Globally, there have been significant efforts to reduce unintended pregnancies and fertility rates.[1,2] One such effort has been the campaign for the use of modern contraceptives among sexually active women.[3] Available evidence shows that these actions have effectively increased contraceptive use among sexually active women.[4] However, most sexually active women who use modern contraceptives use short-term methods such as oral contraceptive pills and condoms, which have been identified as being significantly associated with high rates of discontinuation. This situation has persisted at the expense of long-acting reversible contraceptives (LARCs). LARCs may be viewed as hormonal and copper intrauterine devices and contraceptive implants.[8] Globally not more than 15% of women use LARCs.[9] Europe, for instance, has a varied prevalence of LARC use; the prevalence of LARC use in Poland is 2.9%, while France has a prevalence of about 16%, which is higher than the global proportion of women using LARCs.[10] Other regions, such as Latin America and Asia, have recorded a high prevalence of LARC use.[11,12] However, in sub-Saharan Africa (SSA), the prevalence of LARC use among women is <3%.[13] LARCs are known to have fewer contraindications and are without age restrictions.[14] Moreover, they are cost effective and highly efficacious in preventing unintended pregnancy. Given that LARC use is independent of user compliance, they are more efficacious, with an annual pregnancy rate of <1% for women using LARCs compared with their counterparts who rely on short-term contraceptives such as oral pills and condoms, which have annual pregnancy rates of 9% and 18%, respectively.[8] Thus LARCs are a more efficacious choice. Nevertheless, the availability and use of LARCs remains low among sexually active women, especially those living in SSA.[1,13,18] Studies show that there may be some potential adverse health concerns with the use of LARCs, which serves as a disincentive for many women to accept and utilize them.[19] LARCs are associated with multiple adverse health events, including distortion of menstrual bleeding (either heavy or less than usual bleeding), an increase in the risk of iron deficiency anaemia and pelvic pain. Other factors such as the availability of LARCs, misconceptions about their use and the perceived cost are some of the barriers to the use of LARCs.[22] This raises concerns about how demographic (age, place of residence, etc.) and socio-economic factors (such as wealth quintile, educational level, media exposure) affect LARC use among sexually active women. Given the importance of LARCs in ensuring high efficacy rates and contraceptive continuation,[23] the need to understand the factors that predict their use among sexually active women has become paramount to the realization of better reproductive health outcomes and higher uptake of LARCs. Despite this urgency for a better understanding of the predictors of LARCs, it has received little attention in SSA. Therefore, we sought to bridge this literature gap by examining the prevalence and predictors of LARC use among sexually active women in SSA using the most recent Demographic and Health Survey (DHS) data from 26 countries. We hope this study's findings will be a contributing catalyst to Africa's efforts to reduce maternal mortality and morbidity and significantly reduce unintended pregnancies linked to Sustainable Development Goal 3 by increasing the coverage and use of LARCs.

Methods

Data source and study design

Data utilized in this study were pooled from DHSs conducted in 26 countries in SSA between 2010 and 2019. The countries, years the survey was conducted and sample size for each country are listed in Table 1. The DHS dataset is a nationally representative survey conducted in about 85 low- and-middle-income countries with a core target of sexual and reproductive health issues, including contraceptive use.[24] The women's files, which contain information on women of reproductive age, were used for this study.
Table 1.

Sample size distribution by country and survey year

Survey countriesSurvey yearWeighted sampleWeighted percentage
Central Africa
 Democratic Republic of Congo201410341.84
 Cameroon201914762.63
 Chad20154970.89
 Malawi201613272.37
 Rwanda201531905.69
West Africa
 Burkina Faso201018783.35
 Benin201812412.21
 Gambia20134570.82
 Guinea20186021.07
 Liberia201313742.45
 Nigeria201831005.53
 Niger20127531.34
 Mali201813272.37
 Sierra Leone201324734.41
 Senegal201812672.26
 Togo201410751.92
 Ghana201411332.02
East Africa
 Kenya201444057.86
 Ethiopia201611325.92
 Tanzania201627384.88
 Uganda201136396.49
Southern Africa
 Comoros20123800.68
 Lesotho201417743.16
 Namibia201323374.17
 South Africa201624844.43
 Zimbabwe201837206.63

Source: DHS from 26 SSA countries: 2010–2019.

Sample size distribution by country and survey year Source: DHS from 26 SSA countries: 2010–2019. The DHS employed stratified two-stage sampling techniques to ensure national representativeness.[25] The first stage was the development of a sampling frame containing a list of primary sampling units (PSUs), also known as enumeration areas (EAs), which cover each participating country's entirety. The PSUs are obtained from the latest available national census. Each PSU is further subdivided into standard size segments of about 100–500 households per segment. Random selection of predetermined sample segments is done afterward with probability proportional to the EA's measure of size depending on the number of households in each EA. The second stage entails the systematic selection of households from the list of households previously enumerated by DHS personnel. Women 15–49 y of age and men 15–64 y of age within the selected households are then interviewed. The countries included in the present study had their surveys conducted at different times due to variations in the starting points of DHS data collection in these countries. Nomads and persons in institutional groups, such as prisoners and hotel occupants, are usually excluded from the sample frame. The use of multiple DHS datasets from SSA countries has been previously achieved in other studies.[26,27] Despite the variation in starting points of surveys in various countries, we compared the DHSs among the countries. Permission to utilize the 26 SSA datasets was sought from Monitoring and Evaluation to Assess and Use Results (MEASURE) DHS and the datasets are freely available publicly at https://dhsprogram.com/data/available-datasets.cfm.

Sample size and inclusion criteria

A total of 56 067 women 15–49 y of age who were sexually active (those who had ever had sex) and were using modern contraceptives at the time of the surveys were included in our study; a total of 26 SSA countries were included in the final analysis. These records were used for the analysis because they had complete sets of all the variables of interest in the current study.

Definition of study variables

Outcome variable

The study's outcome variable was ‘LARC,’ which arose from the question about the type of contraceptive women 15–49 y of age who were sexually active were using at the time of the survey. Women who were using modern contraceptives such as condoms, pills, injections, female sterilization, vasectomy, emergency contraceptives and other methods were categorized as not using LARC, while those using an intrauterine device (IUD) or implant were categorized as using LARC.[13,28] Those using methods other than modern contraceptives were excluded from the study.

Explanatory variables

Nine explanatory variables were considered in this study, including age, place of residence, education level, marital status, currently working, wealth index, parity, media exposure and the desire for more children. These variables have been reported to predict LARC use in previous nationally representative studies. Four of the explanatory variables were recoded for better analysis outputs and interpretation. The age of respondents was recoded as 15–24 (0), 25–34 (1) and ≥35 (2). Marital status was recoded into never married (0), married (1), cohabiting (2) and ever married (3). We recoded parity (children ever born) as zero births (0), one to three births (1) and four or more births (2). Finally, exposure to mass media was recoded into no (0) for those who do not read the newspaper, listen to the radio or watch television and yes (1) for those who read the newspaper, listen to the radio or watch television at least once a week.

Statistical analyses

The analysis began with the computation of LARC use among sexually active women of reproductive age in 26 countries in SSA. We then appended the dataset from the countries, generating a total sample of 56 067. We calculated the overall prevalence, proportions of LARC use and chi-square values across the selected sociodemographic characteristics after appending. Binary logistic regression analysis was performed in two models: the first model (model 1) was a bivariate analysis of the country effect on LARC use. The reference country was Angola, due to the limited contraceptive use that has been reported in that country.[31] Model 2 adjusted for the effects of the other explanatory variables to ascertain how these variables influence LARC use. The choice of reference categories for the explanatory variables was determined by similar previous studies.[30,32] Binary logistic regression modelling was employed because our dependent variable (LARC use) was measured as a binary factor. We presented the regression analysis results as crude odds ratios (cORs) and adjusted odds ratio (aORs), with their corresponding 95% confidence intervals (CIs) signifying the precision and significance of the reported OR. The multicollinearity test, which used the variance inflation factor (VIF), revealed no collinearity among the independent variables employed in this study (mean VIF 1.44, maximum VIF 1.96 and minimum VIF 1.06). The inherent survey sample weight to control for undersampling and non-responses was applied. All analyses were carried out with Stata version 16.0 (StataCorp, College Station, TX, USA).

Results

Descriptive results

Figure 1 presents the prevalence of LARC use in each of the 26 SSA countries included in the study. The prevalence of LARC use ranged from 1.94% in Namibia to 54.96% in Benin. Overall, the prevalence of LARC use among sexually active women in the 26 SSA countries was 21.73%.
Figure 1.

Prevalence of LARC use in SSA among sexually active women.

Prevalence of LARC use in SSA among sexually active women. Table 2 shows results of the distribution of sexually active women currently using modern contraceptives in SSA by explanatory variable. The results show a high prevalence of LARC use among sexually active women ages 25–34 y (23.74%), those residing in a rural area (37.91%), those with no education (26.90%), ever married sexually active women (24.14%), women currently employed (23.13%), those within the richest wealth index quintile (23.45%), those with four or more children (24.91%), sexually active women not exposed to mass media (22.00%) and those who were undecided if they desire more children (26.15%). All selected explanatory variables were significant at 0.001, except the place of residence and mass media exposure, with p-values >0.05.
Table 2.

Distribution of sexually active women using LARCs by explanatory variables in SSA (N=56 067)

Using LARCs, n (%)
VariablesWeighted Frequency (n)Weighted PercentageNoYesp-Value (χ2)
Age (years)<0.001
 15–2413 96124.9010 937 (81.80)2433 (18.20)
 25–3424 09242.9717 595 (76.26)5478 (23.74)
 35–4918 01532.1313 494 (78.21)3759 (21.79)
Place of residence0.98
 Urban23 31241.5817 476 (78.28)4850 (21.72)
 Rural32 75558.4224 550 (78.26)6820 (21.74)
Education level<0.001
 No education11 01577.687712 (73.10)2838 (26.90)
 Primary21 68522.3216 365 (78.80)4403 (21.20)
 Secondary/higher23 36717 950 (80.21)4428 (19.79)
Marital status<0.001
 Never married656711.715566 (88.51)722 (11.49)
 Married39 72570.8528 860 (75.86)9185 (24.14)
 Cohabiting765313.655942 (81.08)1386 (18.49)
 Ever married21233.791657 (81.51)375 (21.73)
Currently working<0.001
 No18 38132.7814 281 (81.12)3323 (18.88)
 Yes37 68667.2227 746 (76.87)8347 (23.13)
Wealth index<0.001
 Poorest691612.345226 (78.90)1398 (21.10)
 Poorer941516.797186 (79.69)1831 (20.31)
 Middle10 53118.787935 (78.67)2151 (21.33)
 Richer13 16323.489919 (78.68)2688 (21.32)
 Richest16 04228.6111 761(76.55)3602 (23.45)
Parity<0.001
 No children44487.933782 (88.78)478 (11.22)
 1–3 children29 03951.7922 004 (79.12)5806 (20.88)
 ≥4 children22 58140.2716 240 (75.09)5386 (24.91)
Media exposure0.57
 No11 64420.778698 (78.00)2453 (22.00)
 Yes44 42479.2333 328 (78.34)9217 (21.66)
Desire for more children<0.001
 Want more30 63254.6323 119 (78.80)6218 (21.20)
 Undecided20683.691462 (73.85)518 (26.15)
 No desire23 36741.6817 445 (77.95)4934 (22.05)
Distribution of sexually active women using LARCs by explanatory variables in SSA (N=56 067)

Association between selected explanatory variables and LARC use among sexually active women in SSA

Two models were fitted to examine the association between selected explanatory variables and LARC use, with the results presented in Table 3. Model 1 was a crude model that was unadjusted and model 2 adjusted for the confounders. In model 2, a statistically significant effect of LARC use was found in some selected explanatory variables and countries in SSA.
Table 3.

Bivariate and multivariable models showing the relationship between LARC use and selected explanatory variables among sexually active women in SSA countries

Model 1 (unadjusted)Model 2 (adjusted)
VariablescOR95% CIaOR95% CI
Age (years)
 15–24RefRef
 25–341.40***1.31–1.501.081.00 to 1.17
 ≥351.25***1.16 to 1.350.85**0.77 to 0.95
Place of residence
 UrbanRefRef
 Rural1.000.94 to 1.070.930.85 to 1.01
Education level
 No educationRefRef
 Primary0.73***0.68 to 0.791.020.94 to 1.11
 Secondary/higher0.67***0.62 to 0.731.19***1.08 to 1.32
Marital status
 Never marriedRefRef
 Married2.45***2.20 to 2.731.38***1.17 to 1.63
 Cohabiting1.80***1.59 to 2.031.25**1.06 to 1.47
 Ever married1.75***1.48 to 2.071.180.97 to 1.44
Currently working
 NoRefRef
 Yes1.29***1.22 to 1.371.061.00 to 1.13
Wealth index
 PoorestRefRef
 Poorer0.950.87 to 1.040.930.85 to 1.01
 Middle1.010.92 to 1.110.960.88 to 1.06
 Richer1.010.92 to 1.110.950.85 to 1.04
 Richest1.15**1.04 to 1.261.030.92 to 1.16
Parity
 No childrenRefRef
 1–3 children2.09***1.80 to 2.421.94***1.58 to 2.38
 ≥4 children2.63***2.27 to 3.042.22***1.78 to 2.78
Media exposure
 NoRefRef
 Yes0.980.92 to 1.051.030.96 to 1.11
Desire for more children
 Want moreRefRef
 Undecided1.32***1.15 to 1.511.21**1.05 to 1.39
 No desire1.050.99 to 1.111.12**1.05 to 1.21
Country
 Democratic Republic of CongoRefRef
 Cameroon4.18***3.47 to 5.044.30***3.55 to 5.19
 Chad0.37***0.24 to 0.550.36***0.24 to 0.54
 Malawi0.78*0.64 to 0.950.81*0.66 to 0.99
 Rwanda1.29*1.05 to 1.591.31*1.06 to 1.62
 Burkina Faso1.130.90 to 1.431.110.87 to 1.41
 Benin0.40***0.25 to 0.620.35***0.23 to 0.54
 Gambia1.60***1.26 to 2.042.02***1.55 to 2.63
 Guinea1.120.95 to 1.321.020.86 to 1.21
 Liberia0.49**0.32 to 0.740.48**0.32 to 0.73
 Nigeria0.45***0.32 to 0.640.49***0.35 to 0.70
 Niger0.17***0.13 to 0.230.16***0.12 to 0.22
 Mali3.23***2.62 to 3.983.15***2.55 to 3.88
 Sierra Leone0.960.82 to 1.120.900.76 to 1.05
 Senegal1.71***1.44 to 2.051.55***1.29 to 1.87
Bivariate and multivariable models showing the relationship between LARC use and selected explanatory variables among sexually active women in SSA countries Continued. Model 1: unadjusted model examining the association of selected factors and LARC use. Model 2: adjusted for confounders. Exponentiated coefficients. cOR, Crude Odds Ratio; AOR, Adjusted Odds Ratio; CI, Confidence Interval. Ref: reference. *p<0.05, **p <0.01, ***p<0.001. The likelihood of using LARCs was higher among sexually active women with a secondary or higher education (aOR 1.19 [95% CI 1.08 to 1.32]), those who were married (aOR 1.38 [95% CI 1.17 to 1.63]), those cohabiting (aOR 1.25 (95% CI 1.06 to 1.47]), sexually active women with one to three children (aOR 1.94 [95% CI 1.58 to 2.38]) and those with four or more children (aOR 2.22 [95% CI 1.78 to 2.78]) compared with those without education, those ever married and those with no children, respectively, while those ≥35 y of age were less like to use LARCs (aOR 0.85 [95% CI 0.77 to 0.95]). SSA countries with lower odds of using LARCs in the adjusted model (model 2) included Chad (aOR 0.36 [95% CI 0.24 to 0.54]), Benin (aOR 0.35 [95% CI 0.23 to 0.54]), Nigeria (aOR 0.49 [95% CI 0.35 to 0.70]), Ghana (aOR 0.07 [95% CI 0.05 to 0.11]) and South Africa (aOR 0.34 [95% CI 0.26 to 0.44]), while sexually active women in Cameroon (aOR 4.30 [95% CI 3.55 to 5.19]) had higher odds of using LARCs than any other SSA countries (see Table 3).

Discussion

LARCs may help alleviate the high unmet need for modern contraception in SSA, as they are more cost effective and efficacious and not reliant on user compliance.[33,34] Yet empirical evidence on this is sparse in SSA. This study examined the prevalence and predictors of LARC use among sexually active women using modern contraceptives in 26 SSA countries. The prevalence of LARC use ranged from 4.50% in Niger to 54.96% in Benin and overall the prevalence of LARC use among sexually active women in the 26 SSA countries was 21.73%. This result is higher than in a study conducted among women in SSA that reported LARC use of <3%.[13] Our study found that the likelihood of using LARCs was higher among sexually active women with secondary or higher education compared with those without education. This is because most educated women have increased access to information on the side effects and benefits of using LARC methods.[35] As such, they are aware of the misconceptions and myths that often serve as a deterrent to the use of LARCs. Studies conducted in Kenya,[34] Ethiopia[35,36] and Uganda[37] have shown that higher education is an important predictor of LARC use. This study showed that the prevalence of contraceptive use was higher among sexually active women who were married compared with those who were ever married. This finding is supported by several studies that have demonstrated a positive correlation between marriage and modern contraceptive use.[38,39] However, this contradicts a study conducted in the Democratic Republic of Congo that reported that modern methods and LARC use were lower among married women.[40] This could be related to family or social pressure to give birth quickly after marriage.[40] Therefore there is a need to introduce contraception use among sexually active women during antenatal care visits to encourage child spacing and delay subsequent pregnancy. In this study, sexually active women cohabiting with their partners were more likely to use LARCs. This could be to avoid being exposed to unintended pregnancy, thus leaving them with no choice but to have a positive attitude towards LARC methods.[41] The study also showed that sexually active women with one to three children and those with four or more children had a similar likelihood of using LARCs compared with those with no children. As the number of children increased, the likelihood of using LARCs also increased.[42] A possible explanation for this finding could be that multiparous women tend to receive family planning education and counselling on contraceptive use throughout their pregnancy cycle, thereby increasing their odds of using LARCs.[42] This corroborates findings from other studies where marital status and parity have been identified as important individual characteristics influencing women's reproductive health behaviours, including demand and uptake of modern contraception. Also, sexually active women who were ≥35 y of age were less likely to use LARCs compared with younger women. This is contrary to a study conducted in Kenya that showed more LARC usage among those ages 20–24 y.[46] Increasing LARC usage in SSA countries will require continuous community awareness campaigns to counteract negative perceptions and misinformation.[47] Our study revealed that sexually active women from some SSA countries such as Chad, Benin, Nigeria, Ghana and South Africa had lower odds of using LARCs, while women in Cameroon had higher odds of using LARCs than in any other SSA countries. This may be because there are programmes in place that encourage LARC uptake and this is more markedly documented among sexually active women in Cameroon.[48] The positive efforts of the Cameroon government and family planning providers to increase modern contraceptive practice has ensured higher usage of LARCs.[49] The findings of this study will help policymakers, governments and family planning providers to inform policy regarding the benefits of using LARCs and address the various barriers to the uptake of LARC methods in SSA.

Strengths and limitations

The large sample size from countries in SSA is the major strength of this study, making the findings applicable to sexually active women in SSA. A limitation of this study is that it is a cross-sectional survey, so the progressive order of contraceptive use. The study employed a cross-sectional design, therefore, we could only measure associative effects but not causal effect. The different interventions recommended in this study may not be applicable in all countries in SSA, as economic, cultural and social differences between SSA countries may influence LARC usage. Furthermore, this study analysis did not consider the effects of accessibility to LARCs and women's beliefs related to LARC use.

Policy implications for SSA countries

The findings of this study hold some policy implications for countries in SSA. Generally, women with a secondary or higher education were more likely to use LARCs, which shows the need to target women without education and enlighten them on the benefits of LARCs use. Family planning providers need to counsel women without children concerning their fears about side effects and misconceptions of LARCs and emphasize that LARC methods are reversible.

Conclusions

We found that the use of LARCs in the 26 countries in SSA considered in this study is relatively low. There is a need for sexually active women in SSA to receive counselling on the benefits of using LARCs. Furthermore, governments, policymakers and stakeholders should create awareness by implementing health promotion strategies to increase the need for LARC usage among sexually active women in SSA. Implementation of educational campaigns for sexually active women with lower education should be prioritized in SSA countries. Also, intervention programmes such as campaigns on the efficacy of LARCs in reducing unintended pregnancy and maternal mortality and morbidity should be encouraged among sexually active women with low LARC use.
Table 3.

Continued.

Model 1 (unadjusted)Model 2 (adjusted)
VariablescOR95% CIaOR95% CI
 Togo0.16***0.11 to 0.240.15***0.10 to 0.23
 Ghana0.07***0.05 to 0.990.07***0.05 to 0.11
 Kenya0.79**0.67 to 0.930.77**0.65 to 0.91
 Ethiopia0.890.74 to 1.071.050.87 to 1.28
 Tanzania2.69***2.08 to 3.472.57***1.98 to 3.33
 Uganda1.220.88 to 1.711.180.84 to 1.65
 Comoros1.160.92 to 1.451.210.96 to 1.52
 Lesotho1.020.85 to 1.231.020.84 to 1.24
 Namibia0.990.84 to 1.160.950.80 to 1.13
 South Africa0.33***0.26 to 0.420.34***0.26 to 0.44
 Zimbabwe0.64***0.54 to 0.760.56***0.47 to 0.68
Pseudo-R20.0772

Model 1: unadjusted model examining the association of selected factors and LARC use. Model 2: adjusted for confounders. Exponentiated coefficients. cOR, Crude Odds Ratio; AOR, Adjusted Odds Ratio; CI, Confidence Interval.

Ref: reference.

*p<0.05, **p <0.01, ***p<0.001.

  41 in total

1.  Contraceptive discontinuation and switching among Ghanaian women: evidence from the Ghana Demographic and Health Survey, 2008.

Authors:  Emefa J Modey; Richmond Aryeetey; Richard Adanu
Journal:  Afr J Reprod Health       Date:  2014-03

2.  Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model.

Authors:  Jonathan Bearak; Anna Popinchalk; Leontine Alkema; Gilda Sedgh
Journal:  Lancet Glob Health       Date:  2018-03-05       Impact factor: 26.763

3.  Spatial and socio-demographic determinants of contraceptive use in the Upper East region of Ghana.

Authors:  Fabian Sebastian Achana; Ayaga A Bawah; Elizabeth F Jackson; Paul Welaga; Timothy Awine; Eric Asuo-Mante; Abraham Oduro; John Koku Awoonor-Williams; James F Phillips
Journal:  Reprod Health       Date:  2015-04-02       Impact factor: 3.223

4.  Knowledge of women in family planning and future desire to use contraception: a cross sectional survey in Urban Cameroon.

Authors:  Atem Bethel Ajong; Philip Nana Njotang; Bruno Kenfack; Martin Ndinakie Yakum; Enow Robinson Mbu
Journal:  BMC Res Notes       Date:  2016-07-18

5.  Factors associated with utilization of long-acting and permanent contraceptive methods among women who have decided not to have more children in Gondar city.

Authors:  Chernet Baye Zenebe; Mulat Adefris; Melaku Kindie Yenit; Yalemzewod Assefa Gelaw
Journal:  BMC Womens Health       Date:  2017-09-06       Impact factor: 2.809

6.  Women's autonomy and utilisation of maternal healthcare services in 31 Sub-Saharan African countries: results from the demographic and health surveys, 2010-2016.

Authors:  Chol Chol; Joel Negin; Kingsley Emwinyore Agho; Robert Graham Cumming
Journal:  BMJ Open       Date:  2019-03-13       Impact factor: 2.692

7.  Trends, patterns and determinants of long-acting reversible methods of contraception among women in sub-Saharan Africa.

Authors:  Sunday A Adedini; Olusola Akintoye Omisakin; Oluwaseyi Dolapo Somefun
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

8.  Prevalence and associated factors of contraceptive discontinuation among reproductive-age women in Ethiopia: using 2016 Nationwide Survey Data.

Authors:  Birye Dessalegn Mekonnen; Chalachew Adugna Wubneh
Journal:  Reprod Health       Date:  2020-11-07       Impact factor: 3.223

9.  A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.

Authors:  Luis Bahamondes; Vivian Brache; Olav Meirik; Moazzam Ali; Ndema Habib; Sihem Landoulsi
Journal:  Hum Reprod       Date:  2015-09-25       Impact factor: 6.918

View more
  3 in total

1.  Factors associated with use of long-acting reversible and permanent contraceptives among married women in rural Kenya: A community-based cross-sectional study in Kisii and Kilifi counties.

Authors:  James Orwa; Samwel Maina Gatimu; Anthony Ngugi; Alfred Agwanda; Marleen Temmerman
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

2.  Long-acting reversible contraceptives utilization and its determinants among married Yemeni women of childbearing age who no longer want children.

Authors:  Michael Boah; Abdul-Nasir Issah; Isaac Demuyakor; Dalia Hyzam
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

3.  Spatial distribution and factors associated with modern contraceptive use among women of reproductive age in Nigeria: A multilevel analysis.

Authors:  Obasanjo Afolabi Bolarinwa; Zemenu Tadesse Tessema; James Boadu Frimpong; Abdul-Aziz Seidu; Bright Opoku Ahinkorah
Journal:  PLoS One       Date:  2021-12-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.